Safety and immunogenicity of a modified Omicron-adapted inactivated vaccine in healthy adults: a randomized, double-blind, active-controlled Phase III clinical trial

Overview of attention for article published in Frontiers in immunology, September 2023

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (51st percentile)
Above-average Attention Score compared to outputs of the same age and source (62nd percentile)

Mentioned by

twitter: 4 X users

Readers on

mendeley: 12 Mendeley

Summary X

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 69,308 followers.

Safety and immunogenicity of a modified Omicron-adapted inactivated vaccine in healthy adults: a randomized, double-blind, active-controlled Phase III clinical trial https://t.co/4KFgvKswqt

09 Oct 2023

Reply Repost Favourite

RT @BagaiDr: Safety & immunogenicity of modified Omicron-adapted inactivated vac in healthy adults:double-blind,active-controlled Phase III…

18 Sep 2023

Reply Repost Favourite

Safety & immunogenicity of modified Omicron-adapted inactivated vac in healthy adults:double-blind,active-controlled Phase III RCT. within 3C cohort (3C+1O vs. 3C+1C), (GMT) ratio & (CI) was 1.64, with lower CI ≥1; a GMT ratio of 1.84 for 2C+1O vs

18 Sep 2023

Reply Repost Favourite

New Research: Safety and immunogenicity of a modified Omicron-adapted inactivated vaccine in healthy adults: a randomized, double-blind, active-controlled Phase III clinical trial: Background Updated vaccine strategies are needed to protect… #immunology h

18 Sep 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.